Corvus Pharmaceuticals Inc (CRVS) Hedge Fund & Institutional Holdings (Q2 2026)

CRVS ranks #3321 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

CRVS is a top-conviction position for Adams Street Partners LLC — at 11.1% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in CRVS belongs to Orbimed Advisors LLC, but the position matters far more to Adams Street Partners LLC, who has 11.1% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

California State Teachers Retirement System has added to its CRVS position for two straight quarters, increasing it by $70.9M to reach $70.9M today.

CRVS is down 0.5% today, but institutions show net buying of $143.4M this quarter — a divergence between today's price move and the underlying institutional flow.

CRVS reported a net loss of $15.3M in its latest fiscal year.

• Not yet profitable — net loss of $15.3M in the latest fiscal year
• Net income improved year over year, from -$62.3M to -$15.3M
• Operating cash flow was negative, using $32.8M in cash
• Current ratio of 6.21x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.16x equity — within a conventional range